Combining training programs for children with ADHD and their parents
Evaluating the Efficacy of Sequenced Central Executive and Behavioral Parent Training for Children With ADHD
This study tests whether combining a memory training program for kids with ADHD and a parenting program can help improve their symptoms and family relationships.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 8 Years to 12 Years |
| Sex | All |
| Sponsor | Florida State University Academic / other |
| Locations | 1 site (Tallahassee, Florida) |
| Trial ID | NCT05492422 on ClinicalTrials.gov |
What this trial studies
This project aims to integrate two evidence-based treatments for school-aged children diagnosed with ADHD: Central Executive Training (CET) and Behavioral Parent Training (BPT). CET is a computerized intervention designed to enhance children's working memory and alleviate ADHD symptoms, while BPT focuses on improving family dynamics and reducing oppositional-defiant behaviors by modifying parenting strategies. The study hypothesizes that delivering CET prior to BPT will yield complementary benefits for the children and their families. The effectiveness of this combined approach will be evaluated through various assessments of ADHD symptoms and family functioning.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 8-12 with a principal diagnosis of ADHD and elevated ADHD symptoms as reported by parents and teachers.
Not a fit: Patients with severe neurological impairments, significant psychiatric disorders, or those who do not speak English may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve ADHD symptoms and family relationships for affected children and their parents.
How similar studies have performed: Previous studies have shown promise in using combined behavioral interventions for ADHD, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion: 1. Children ages 8-12 with principal ADHD diagnoses (via K-SADS); and 2. parent AND teacher ratings in clinical/borderline range based on age and sex on ADHD Rating Scale (ADHD-5) or Behavior Assessment Scale for Children (BASC-3) Attention Problems/Hyperactivity subscales (i.e., 90th percentile or higher based on both informants). All DSM-5 ADHD presentations will be eligible. Exclusion: 1. gross neurological, sensory, or motor impairment; 2. history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with participation (e.g., disruptive mood dysregulation, intermittent explosive, reactive attachment, substance use); 3. intellectual disability or Wechsler Intelligence Scale for Children (WISC-V) short-form standard score \<70; 4. conditions requiring acute intervention, e.g., active suicidality; and 5. non-English speaking child or parent.
Where this trial is running
Tallahassee, Florida
- Florida State University — Tallahassee, Florida, United States (Recruiting)
Study contacts
- Study coordinator: Children's Learning Clinic
- Email: clc@psy.fsu.edu
- Phone: 8506457423
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.